8-K: Elite Health Systems Initiates Private Placement and Pursues Strategic Acquisition

Elite Health Systems Inc. has commenced a private placement to raise up to $5 million and entered a non-binding letter of intent to acquire Physician Support Systems, Inc., while its subsidiary Elite Health Plan received conditional CMS approval for its 2026 Medicare Advantage application.

Summary

• Elite Health Systems Inc. (the Company) commenced a private placement of common stock on July 2, 2025, aiming to raise gross proceeds of a minimum of $2,000,000 and a maximum of $5,000,000 at a price of $0.95 per share.
• The Company currently has 3,509,076 authorized shares available for the private placement.
• To issue more shares for the private placement and the PSS Transaction, the Company will seek to amend its Certificate of Incorporation to increase authorized common stock by 25,000,000 shares, bringing the total to 50,000,000 shares, subject to stockholder approval.
• The Company intends to use substantially all net proceeds from the private placement for the continued development of Elite Health Plan, Inc. (Elite Health), integration of the PSS Transaction acquisition, and supporting operational activities.
• Elite Health, a wholly-owned subsidiary formed in 2017, aims to operate as a Medicare Advantage plan for seniors, initially in California's San Bernardino, Los Angeles, and Riverside counties.
• Elite Health received conditional approval from the Centers for Medicare and Medicaid Services (CMS) for its Contract Year (CY) 2026 Medicare Advantage/Medicare Prescription Drug (MA-Only/MA-PD) application, as previously disclosed on June 3, 2025.
• Final CMS approval for Elite Health's contract requires approval of its bid (including formulary) and completion of all pre-implementation activities, including system and data testing.
• On July 2, 2025, the Company entered a non-binding letter of intent to acquire 100% of Physician Support Systems, Inc. (PSS) from its stockholders, Dr. Prasad Jeereddi and Dr. Praveena Jeereddi, in exchange for 3,158,000 shares of the Company's common stock.
• The PSS Transaction is contingent on satisfactory due diligence, execution of a definitive Acquisition Agreement, and approval by the Company's stockholders of both the Acquisition Agreement and the increase in authorized common stock.

Sentiment

Score: 7

Explanation: The document outlines positive strategic moves including a capital raise and a potential acquisition, alongside a crucial conditional regulatory approval for a key subsidiary. These indicate forward momentum and growth potential. However, the non-binding nature of the acquisition, the need for shareholder approval for share increase, and the related-party aspect introduce some elements of caution and uncertainty, preventing a higher score.

Positives

• Commencement of a private placement to raise significant capital (up to $5,000,000) for business development and strategic integration.
• Elite Health, a key subsidiary, received conditional CMS approval for its CY 2026 Medicare Advantage application, a crucial step towards becoming a managed care organization.
• Entry into a non-binding letter of intent to acquire Physician Support Systems, Inc. (PSS), which could expand the Company's service offerings and capabilities.

Negatives

• The Company requires stockholder approval to increase authorized shares by 25,000,000 to facilitate the full private placement and the PSS Transaction.
• Elite Health has a limited operating history, having been formed in 2017.
• The PSS Transaction is currently a non-binding letter of intent and is subject to multiple contingencies, including due diligence, definitive agreement execution, and stockholder approval.
• The PSS Transaction involves related parties, as the sellers (Dr. Prasad Jeereddi and Dr. Praveena Jeereddi) are the Company's CEO and his daughter, respectively.

Risks

• The proposed increase in authorized common stock and the PSS Transaction are subject to and conditioned upon the approval of the Company's stockholders.
• Elite Health's ability to enter into a contract with CMS as an MA/MA-PD organization is contingent on CMS approving its bid (including formulary) and completing all required pre-implementation activities, including system and data testing.
• Elite Health has a limited operating history, which may pose challenges in establishing and scaling its managed care operations.
• The non-binding nature of the PSS Transaction letter of intent means there is no guarantee the acquisition will be completed.
• Potential dilution for existing shareholders from the issuance of new shares in the private placement and for the PSS Transaction.

Future Outlook

The Company anticipates an initial closing of the private placement within a month and expects multiple closings. Net proceeds will primarily fund the continued development of Elite Health, integration of the PSS acquisition, and related operational activities. Elite Health plans to initially operate in specific California counties and explore expansion within California and other states like Nevada. The Company will file a proxy statement recommending stockholder approval for the share increase and PSS transaction.

Management Comments

• The Board of Directors of the Company will recommend to the stockholders of the Company, among other things, that the stockholders approve the Amendment (to increase authorized shares).

Industry Context

This announcement positions Elite Health Systems within the evolving U.S. healthcare landscape, specifically targeting the growing Medicare Advantage market. The acquisition of Physician Support Systems, Inc. suggests a strategy to integrate or expand physician support services, which is a common trend among managed care organizations seeking to optimize patient care and operational efficiency. The focus on California and Nevada indicates a regional growth strategy in key senior population centers.

Comparison to Industry Standards

• NA

Corporate Governance

Related Party Transactions

• The Company entered into a non-binding letter of intent to acquire Physician Support Systems, Inc. (PSS) from Dr. Prasad Jeereddi and Dr. Praveena Jeereddi. Dr. Prasad Jeereddi is the Company's Chief Executive Officer and owns 51% of PSS, while Dr. Praveena Jeereddi (Dr. Prasad Jeereddi's daughter) owns 49% of PSS.

Stakeholder Impact

• Shareholders: Potential for dilution from the private placement and the PSS acquisition shares, but also potential for growth and increased value if the capital raise and acquisition are successful and Elite Health's Medicare Advantage plan thrives.
• Future Medicare Advantage Members: Elite Health's conditional CMS approval and planned operations in California counties could provide new healthcare options for seniors.
• Employees: Potential for growth and integration activities related to the PSS acquisition and Elite Health's expansion.

Next Steps

• Prepare and file a proxy statement with the SEC.
• Seek stockholder approval for the amendment to increase authorized common stock to 50,000,000 shares.
• Seek stockholder approval for the Acquisition Agreement related to the PSS Transaction.
• File a Form D with the SEC within 15 days of the first date of sale in the private placement.
• Complete an initial closing of the private placement within a month from its commencement, with multiple closings expected.
• Complete satisfactory due diligence for the PSS Transaction.
• Execute a definitive Acquisition Agreement for the PSS Transaction.
• Elite Health must complete all other required pre-implementation activities, including system and data testing, and receive CMS approval for its bid (including formulary) to enter into the contract as an MA/MA-PD organization.
• Elite Health expects to initially operate in San Bernardino, Los Angeles, and Riverside counties, and continue exploring expansion and applicable licensure in other parts of California and other states including Nevada.

Key Dates

Keywords

Private Placement, Equity Securities, Acquisition, Medicare Advantage, CMS, Healthcare, Managed Care, Form 8-K, Stockholder Approval, Capital Raise, Physician Support Systems, Elite Health Plan